William Blair & Company’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.3M Sell
215,089
-862
-0.4% -$76.8K 0.05% 254
2025
Q4
$17.1M Sell
215,951
-26,494
-11% -$2.08M 0.05% 261
2025
Q3
$19.4M Sell
242,445
-3,223
-1% -$275K 0.05% 236
2025
Q2
$22.3M Sell
245,668
-7,901
-3% -$721K 0.06% 212
2025
Q1
$23.8M Sell
253,569
-16,038
-6% -$1.44M 0.07% 197
2024
Q4
$24.5M Sell
269,607
-6,822
-2% -$651K 0.07% 202
2024
Q3
$28.7M Buy
276,429
+1,743
+0.6% +$178K 0.08% 186
2024
Q2
$26.7M Sell
274,686
-3,076
-1% -$284K 0.08% 178
2024
Q1
$25M Buy
277,762
+545
+0.2% +$46.2K 0.08% 185
2023
Q4
$22.1M Sell
277,217
-7,453
-3% -$560K 0.08% 192
2023
Q3
$20.2M Sell
284,670
-11,558
-4% -$864K 0.08% 194
2023
Q2
$22.8M Sell
296,228
-11,735
-4% -$908K 0.08% 184
2023
Q1
$23.1M Buy
307,963
+509
+0.2% +$37.8K 0.09% 185
2022
Q4
$24.2M Sell
307,454
-15,772
-5% -$1.18M 0.11% 171
2022
Q3
$22.7M Buy
323,226
+12,551
+4% +$984K 0.1% 174
2022
Q2
$24.9M Sell
310,675
-634
-0.2% -$49.6K 0.11% 168
2022
Q1
$23.6M Sell
311,309
-6,090
-2% -$482K 0.08% 204
2021
Q4
$27.1M Sell
317,399
-18,219
-5% -$1.42M 0.09% 208
2021
Q3
$25.4M Sell
335,618
-18,183
-5% -$1.44M 0.09% 205
2021
Q2
$28.8M Sell
353,801
-1,445
-0.4% -$118K 0.1% 184
2021
Q1
$28M Sell
355,246
-8,791
-2% -$689K 0.11% 175
2020
Q4
$31.1M Sell
364,037
-9,178
-2% -$759K 0.11% 167
2020
Q3
$28.8M Buy
373,215
+2,482
+0.7% +$189K 0.12% 161
2020
Q2
$27.2M Buy
370,733
+6,549
+2% +$465K 0.13% 148
2020
Q1
$24.2M Sell
364,184
-32,876
-8% -$2.32M 0.15% 138
2019
Q4
$27.3M Sell
397,060
-1,843
-0.5% -$126K 0.14% 154
2019
Q3
$29.3M Sell
398,903
-7,115
-2% -$516K 0.17% 129
2019
Q2
$29.1M Sell
406,018
-42,433
-9% -$3.01M 0.17% 131
2019
Q1
$30.7M Sell
448,451
-31,989
-7% -$2.07M 0.19% 117
2018
Q4
$28.6M Sell
480,440
-89,305
-16% -$5.59M 0.21% 113
2018
Q3
$38.1M Sell
569,745
-178,499
-24% -$11.9M 0.23% 104
2018
Q2
$48.5M Sell
748,244
-95,853
-11% -$6.27M 0.33% 77
2018
Q1
$60.5M Sell
844,097
-80,391
-9% -$5.79M 0.43% 58
2017
Q4
$69.8M Sell
924,488
-15,543
-2% -$1.13M 0.47% 52
2017
Q3
$68.5M Sell
940,031
-18,115
-2% -$1.31M 0.51% 50
2017
Q2
$71M Sell
958,146
-16,996
-2% -$1.26M 0.53% 49
2017
Q1
$71.3M Buy
975,142
+6,441
+0.7% +$451K 0.58% 41
2016
Q4
$63.4M Buy
968,701
+21,340
+2% +$1.46M 0.57% 47
2016
Q3
$70.2M Buy
947,361
+1,116
+0.1% +$82.5K 0.62% 41
2016
Q2
$69.3M Buy
946,245
+36,649
+4% +$2.61M 0.65% 41
2016
Q1
$64.3M Sell
909,596
-5,980
-0.7% -$398K 0.61% 43
2015
Q4
$61M Buy
915,576
+10,407
+1% +$692K 0.57% 45
2015
Q3
$57.4M Sell
905,169
-1,704,245
-65% -$111M 0.5% 45
2015
Q2
$171M Buy
2,609,414
+110,515
+4% +$7.5M 0.26% 108
2015
Q1
$173M Sell
2,498,899
-531,251
-18% -$36.7M 0.27% 111
2014
Q4
$210M Buy
3,030,150
+123,122
+4% +$8.32M 0.34% 67
2014
Q3
$190M Buy
2,907,028
+21,190
+0.7% +$1.4M 0.32% 72
2014
Q2
$197M Buy
2,885,838
+858,166
+42% +$57.5M 0.32% 74
2014
Q1
$132M Buy
2,027,672
+94,736
+5% +$5.97M 0.22% 140
2013
Q4
$126M Buy
1,932,936
+126,137
+7% +$8.07M 0.21% 140
2013
Q3
$107M Buy
1,806,799
+25,239
+1% +$1.5M 0.19% 158
2013
Q2
$102M Buy
+1,781,560
New +$106M 0.2% 144

Other funds holding CL

William Blair & Company's CL Position: Q1 2026 in Review

William Blair & Company reduced its Colgate-Palmolive (CL) stake by 0.4% in Q1 2026, selling an estimated $76.8K and leaving 215,089 shares worth $18.3M. The position accounts for 0.05% of the portfolio, ranked #254.

William Blair & Company first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $210M in Q4 2014. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • William Blair & Company held 215,089 shares of Colgate-Palmolive worth $18.3M as of Q1 2026.
  • William Blair & Company sold 862 Colgate-Palmolive shares in Q1 2026, an estimated $76.8K.
  • Colgate-Palmolive made up 0.05% of William Blair & Company's portfolio in Q1 2026, its #254 holding.
  • William Blair & Company first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • William Blair & Company's Colgate-Palmolive position peaked at $210M in Q4 2014.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.